...
首页> 外文期刊>American Journal of Infection Control >Impact of a hospital-wide antimicrobial formulary intervention on the incidence of multidrug-resistant gram-negative bacteria.
【24h】

Impact of a hospital-wide antimicrobial formulary intervention on the incidence of multidrug-resistant gram-negative bacteria.

机译:全院抗菌药物处方干预对耐多药革兰氏阴性菌发生率的影响。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We examined the impact of an antimicrobial formulary change, based on reduction in third-generation cephalosporin use, on resistant gram-negative pathogens in a tertiary hospital. No significant changes were demonstrated in their incidence per 1000 patient-days. Otherwise, there was a significant decrease in rate of extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae (63.1% to 52.5%, P = .04) and third-generation cephalosporin-resistant Enterobacter species (31.4% to 25%, P = .04) between the 2 study periods. On the other hand, there was also a significant increase in rate of ampicillin-sulbactam-resistant Acinetobacter baumannii (8% to 47%, P = .01) after the implementation of the formulary intervention.
机译:我们基于三级头孢菌素使用量的减少,对三级医院耐药革兰氏阴性病原体的抗菌配方变化的影响进行了研究。每千个患者日的发病率没有显着变化。否则,产生超广谱β-内酰胺酶(ESBL)的肺炎克雷伯菌(63.1%至52.5%,P = .04)和第三代头孢菌素耐药肠杆菌(31.4%至25%)的比率显着下降。 ,P = .04)在两个研究期之间。另一方面,实施处方干预后,氨苄西林-舒巴坦耐药鲍曼不动杆菌的发生率也显着增加(8%至47%,P = 0.01)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号